These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10473194)

  • 1. Synthesis and evaluation of copper radiopharmaceuticals with mixed bis(thiosemicarbazone) ligands.
    Ackerman LJ; West DX; Mathias CJ; Green MA
    Nucl Med Biol; 1999 Jul; 26(5):551-4. PubMed ID: 10473194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mixed bis(thiosemicarbazone) ligands for the preparation of copper radiopharmaceuticals: synthesis and evaluation of tetradentate ligands containing two dissimilar thiosemicarbazone functions.
    Lim JK; Mathias CJ; Green MA
    J Med Chem; 1997 Jan; 40(1):132-6. PubMed ID: 9016338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Species-dependent binding of copper(II) bis(thiosemicarbazone) radiopharmaceuticals to serum albumin.
    Mathias CJ; Bergmann SR; Green MA
    J Nucl Med; 1995 Aug; 36(8):1451-5. PubMed ID: 7629593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationships for metal-labeled blood flow tracers: comparison of keto aldehyde bis(thiosemicarbazonato)copper(II) derivatives.
    John EK; Green MA
    J Med Chem; 1990 Jun; 33(6):1764-70. PubMed ID: 2342070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Copper(II) bis(thiosemicarbazone) complexes as potential tracers for evaluation of cerebral and myocardial blood flow with PET.
    Green MA; Klippenstein DL; Tennison JR
    J Nucl Med; 1988 Sep; 29(9):1549-57. PubMed ID: 3261785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Species dependence of [64Cu]Cu-Bis(thiosemicarbazone) radiopharmaceutical binding to serum albumins.
    Basken NE; Mathias CJ; Lipka AE; Green MA
    Nucl Med Biol; 2008 Apr; 35(3):281-6. PubMed ID: 18355683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of copper-labeled bifunctional chelate-albumin conjugates for blood pool imaging.
    Anderson CJ; Rocque PA; Weinheimer CJ; Welch MJ
    Nucl Med Biol; 1993 May; 20(4):461-7. PubMed ID: 8504288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human biodistribution and dosimetry of the PET perfusion agent copper-62-PTSM.
    Wallhaus TR; Lacy J; Whang J; Green MA; Nickles RJ; Stone CK
    J Nucl Med; 1998 Nov; 39(11):1958-64. PubMed ID: 9829589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production and tumour uptake of [64Cu]Pyruvaldehyde-bis (N4-methylthiosemicarbazone) for PET and/or therapeutic purposes.
    Jalilian AR; Rowshanfarzad P; Kamrani YY; Shafaii K; Mirzaii M
    Nucl Med Rev Cent East Eur; 2007; 10(1):6-11. PubMed ID: 17694494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a potential generator-produced PET tracer for cerebral perfusion imaging: single-pass cerebral extraction measurements and imaging with radiolabeled Cu-PTSM.
    Mathias CJ; Welch MJ; Raichle ME; Mintun MA; Lich LL; McGuire AH; Zinn KR; John EK; Green MA
    J Nucl Med; 1990 Mar; 31(3):351-9. PubMed ID: 2308007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a solvent extraction technique for determination of Cu-PTSM in blood.
    Mathias CJ; Bergmann SR; Green MA
    Nucl Med Biol; 1993 Apr; 20(3):343-9. PubMed ID: 8485494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of regional myocardial perfusion with generator-produced 62Cu-PTSM and positron emission tomography.
    Herrero P; Markham J; Weinheimer CJ; Anderson CJ; Welch MJ; Green MA; Bergmann SR
    Circulation; 1993 Jan; 87(1):173-83. PubMed ID: 8419005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of regional myocardial and renal blood flow with copper-PTSM and positron emission tomography.
    Shelton ME; Green MA; Mathias CJ; Welch MJ; Bergmann SR
    Circulation; 1990 Sep; 82(3):990-7. PubMed ID: 2394015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subcellular distribution of tissue radiocopper following intravenous administration of 67Cu-labeled Cu-PTSM.
    Baerga ID; Maickel RP; Green MA
    Int J Rad Appl Instrum B; 1992 Aug; 19(6):697-701. PubMed ID: 1522024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of the new zinc-62/copper-62 generator: an effective labeling method for 62Cu-PTSM.
    Matsumoto K; Fujibayashi Y; Yonekura Y; Wada K; Takemura Y; Konishi J; Yokoyama A
    Int J Rad Appl Instrum B; 1992 Jan; 19(1):39-44. PubMed ID: 1577613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Copper-62-labeled pyruvaldehyde bis(N4-methylthiosemicarbazonato)copper(II): synthesis and evaluation as a positron emission tomography tracer for cerebral and myocardial perfusion.
    Green MA; Mathias CJ; Welch MJ; McGuire AH; Perry D; Fernandez-Rubio F; Perlmutter JS; Raichle ME; Bergmann SR
    J Nucl Med; 1990 Dec; 31(12):1989-96. PubMed ID: 2266398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A potential copper radiopharmaceutical for imaging the heart and brain: copper-labeled pyruvaldehyde bis(N4-methylthiosemicarbazone).
    Green MA
    Int J Rad Appl Instrum B; 1987; 14(1):59-61. PubMed ID: 3583756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and formulation of [
    Green MA; Mathias CJ
    Appl Radiat Isot; 2022 Apr; 182():110119. PubMed ID: 35093818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Cu-PTSM as a tracer of tumor perfusion: comparison with labeled microspheres in spontaneous canine neoplasms.
    Mathias CJ; Green MA; Morrison WB; Knapp DW
    Nucl Med Biol; 1994 Jan; 21(1):83-7. PubMed ID: 9234268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cu(II) bis(thiosemicarbazone) radiopharmaceutical binding to serum albumin: further definition of species dependence and associated substituent effects.
    Basken NE; Green MA
    Nucl Med Biol; 2009 Jul; 36(5):495-504. PubMed ID: 19520290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.